Literature DB >> 25738917

RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.

Yu-Qiu Hao1, Zhen-Zhong Su1, Xue-Jiao Lv1, Ping Li2, Peng Gao1, Chen Wang1, Yue Bai1, Jie Zhang1.   

Abstract

Cigarette smoking is closely associated with various respiratory diseases. Oxidants and carcinogens in cigarettes are reported to induce various airway epithelial injuries. However, the underlying mechanisms remain unclear. The aims of the present study were to determine the involvement of RNA-binding motif protein 5 (RBM5) and Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury, as well as the interaction between both. A549 cells were treated with cigarette smoke extract (CSE). The MTT assay was used to assess the effects of CSE on cell viability. The levels of RBM5 and Wnt/β-catenin/GSK3β were detected by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis. A luciferase assay was used to assess the activity of β-catenin/T-cell factor (TCF) signaling. The results revealed that CSE inhibited A549 cell viability in both a dose- and time-dependent manner. Cytosolic and nuclear β-catenin levels were significantly increased following CSE treatment, compared with those in the control cells (P<0.05). The luciferase activity in CSE-exposed cells transfected with the TCF luciferase reporter wild-type plasmid (pGL3-OT) was significantly greater than that in cells without CSE exposure (33,167±3,085 vs. 19,978±1,916, respectively, P<0.05). Both the mRNA and protein levels of RBM5 in the CSE-treated cells were significantly reduced compared to the levels in the controls (all P<0.05). The overexpression of RBM5 inhibited Wnt/β-catenin signaling in the A549 cells, while silencing of RBM5 enhanced Wnt/β-catenin signaling. The β-catenin/TCF signaling inhibitor ICG-001 had no apparent effect on the RBM5 levels. Downregulation of RBM5 and activation of Wnt/β-catenin signaling are involved in CSE-induced alveolar epithelial injury. RBM5 acts as an upstream molecule that negatively regulates the activity of Wnt/β-catenin signaling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25738917     DOI: 10.3892/or.2015.3828

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  The β-catenin/CBP signaling axis participates in sepsis-induced inflammatory lung injury.

Authors:  Xia Cheng; Dandan Liu; Xinxin Ren; You Nie; Yibing Zhao; Ruyu Chen; Hongwei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

2.  Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.

Authors:  Zhenzhong Su; Ke Wang; Ranwei Li; Jinzhi Yin; Yuqiu Hao; Xuejiao Lv; Junyao Li; Lijing Zhao; Yanwei Du; Ping Li; Jie Zhang
Journal:  World J Surg Oncol       Date:  2016-02-29       Impact factor: 2.754

3.  RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.

Authors:  Yuanpei Jiang; Hongling Sheng; Lei Meng; Hongsheng Yue; Bo Li; Aijun Zhang; Yanan Dong; Yuguang Liu
Journal:  World J Surg Oncol       Date:  2017-01-06       Impact factor: 2.754

4.  Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.

Authors:  Bidong Ma; Zhiyou Huang; Qian Wang; Jizhou Zhang; Bin Zhou; Jiaohong Wu
Journal:  BioData Min       Date:  2019-10-21       Impact factor: 2.522

Review 5.  RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis.

Authors:  Yingshu Cao; Xin Di; Qinghua Zhang; Ranwei Li; Ke Wang
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

6.  RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.

Authors:  Yingyue Cao; Jianxiong Geng; Xin Wang; Qingwei Meng; Shanqi Xu; Yaoguo Lang; Yongxu Zhou; Lishuang Qi; Zijie Wang; Zixin Wei; Yan Yu; Shi Jin; Bo Pan
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 7.  Aberrant Post-Transcriptional Regulation of Protein Expression in the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Noof Aloufi; Aeshah Alluli; David H Eidelman; Carolyn J Baglole
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

8.  Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.

Authors:  Hye Sung Won; Kyung Mee Lee; Ju Eon Oh; Eun Mi Nam; Kyoung Eun Lee
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.